<?xml version="1.0" encoding="UTF-8"?><meta xmlns:fo="http://www.w3.org/1999/XSL/Format" xmlns="http://www.w3.org/1999/xhtml" xmlns:xi="http://www.w3.org/2001/XInclude" http-equiv="Content-Type" content="text/html; charset=utf-8" />
<style xmlns:fo="http://www.w3.org/1999/XSL/Format" xmlns:xi="http://www.w3.org/2001/XInclude" type="text/css">
   @media screen{
   .test-story-main legend{
   text-align:center;
   font-size:110%;
   font-weight:bold;
   }
   .test-story-main .nav-tabs{
   font-weight:bold;
   }
   .test-story-main .tds_obxGrpSpl{
   background:#B8B8B8;
   }
   .test-story-main maskByMediaType{
   display:table;
   }
   .test-story-main table tbody tr th{
   font-size:95%
   }
   .test-story-main table tbody tr td{
   font-size: 110%;
   }
   .test-story-main table tbody tr th{
   text-align:left;
   background:#C6DEFF;
   font-size:100%;
   }
   .test-story-main fieldset{
   text-align:center;
   }
   .test-story-main table{
   width:98%;
   border:1px groove;
   table-layout:fixed;
   margin:0 auto;
   border-collapse:collapse;
   }
   .test-story-main table tr{
   border:2px groove;
   
   }
   .test-story-main table th{
   border:2px groove;
   
   }
   .test-story-main table td{
   border:1px groove;
   
   }
   .test-story-main table thead{
   border:1px groove;
   background:#446BEC;
   text-align:center;
   }
   .test-story-main .separator{
   background:rgb(240, 240, 255);
   text-align:left;
   }
   .test-story-main table tbody tr td{
   text-align:left
   }
   .test-story-main .noData{
   background:#B8B8B8;
   }
   .test-story-main .childField{
   background:#B8B8B8;
   }
   .test-story-main .title{
   text-align:left;
   }
   .test-story-main h3{
   text-align:center;
   page-break-inside:avoid;
   }
   .test-story-main h2{
   text-align:center;
   }
   .test-story-main h1{
   text-align:center;
   }
   .test-story-main .pgBrk{
   padding-top:15px;
   }
   .test-story-main .er7Msg{
   width:100%;
   }
   .test-story-main .embSpace{
   padding-left:15px;
   }
   .test-story-main .accordion-heading{
   font-weight:bold;
   font-size:90%;
   }
   .test-story-main .accordion-heading i.fa:after{
   content:"\00a0 ";
   }
   .test-story-main panel{
   margin:10px 5px 5px 5px;
   }
   }
   
   @media print{
   .test-story-main legend{
   text-align:center;
   font-size:110%;
   font-weight:bold;
   }
   .test-story-main .nav-tabs{
   font-weight:bold;
   }
   .test-story-main .obxGrpSpl{
   background:#B8B8B8;
   }
   .test-story-main maskByMediaType{
   display:table;
   }
   .test-story-main table tbody tr th{
   font-size:90%
   }
   .test-story-main table tbody tr td{
   font-size:90%;
   }
   .test-story-main table tbody tr th{
   text-align:left;
   background:#C6DEFF;
   
   }
   .test-story-main table thead tr th{
   text-align:center;
   background:#4682B4;
   
   }
   .test-story-main fieldset{
   text-align:center;
   page-break-inside:avoid;
   }
   .test-story-main table{
   width:98%;
   border:1px groove;
   table-layout:fixed;
   margin:0 auto;
   page-break-inside:avoid;
   border-collapse:collapse;
   }
   .test-story-main table tr{
   border:2px groove;
   }
   .test-story-main table th{
   border:2px groove;
   }
   .test-story-main table td{
   border:1px groove;
   }
   .test-story-main table thead{
   border:1px groove;
   background:#446BEC;
   text-align:left;
   }
   .test-story-main .separator{
   background:rgb(240, 240, 255);
   text-align:left;
   }
   .test-story-main table tbody tr td{
   text-align:left;
   }
   .test-story-main .noData{
   background:#B8B8B8;
   }
   .test-story-main .childField{
   background:#B8B8B8;
   }
   .test-story-main .tds_title{
   text-align:left;
   margin-bottom:1%
   }
   .test-story-main h3{
   text-align:center;
   }
   .test-story-main h2{
   text-align:center;
   }
   .test-story-main h1{
   text-align:center;
   }
   .test-story-main .tds_pgBrk{
   page-break-after:always;
   }
   .test-story-main #er7Message table{
   border:0px;
   width:80%
   }
   .test-story-main #er7Message td{
   background:#B8B8B8;
   font-size:65%;
   margin-top:6.0pt;
   border:0px;
   text-wrap:preserve-breaks;
   white-space:pre;
   }
   .test-story-main .er7Msg{
   width:100%;
   font-size:80%;
   }
   .test-story-main .er7MsgNote{
   width:100%;
   font-style:italic;
   font-size:80%;
   }
   .test-story-main .embSpace{
   padding-left:15px;
   }
   .test-story-main .embSubSpace{
   padding-left:25px;
   }
   .test-story-main .accordion-heading{
   font-weight:bold;
   font-size:90%;
   }
   .test-story-main .accordion-heading i.fa:after{
   content:"\00a0 ";
   }
   .test-story-main panel{
   margin:10px 5px 5px 5px;
   }
   }
</style>
<!-- generated by TestStory_v1.xslt Version:1.0   Profile:TestStory-->
<fieldset>
	<div class="test-story-main">
		<tabset>
			<tab heading="FULL"  vertical="false">
				<div class="panel-body">
					<div class="panel-body"><table><tr><th>Description</th></tr><tr><td><p>The nurse documents administration lot number for the Hepatitis B vaccine:</p><p style="margin-left: 20px;">- Is prevented from ordering the Hepatitis B lot as it has expired.</p><p style="margin-left: 20px;">- Documents administration from a different lot that is not expired.</p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Comments</th></tr><tr><td><p>No Comments</p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Pre-condition</th></tr><tr><td><p>Order is placed for Hepatitis B vaccine.</p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Post-Condition</th></tr><tr><td><p>The provider has been notified of the expired Hepatitis B vaccination lot. Documentation of a lot to be administered that is not expired is recorded in the EMR.</p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Test Objectives</th></tr><tr><td><p><strong>Notify of Vaccine Dose Expiration:&nbsp;</strong>The EHR or other clinical software system notifies the provider administering a vaccine if the dose chosen for administration is expired.</p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Evaluation Criteria</th></tr><tr><td><!--[if gte mso 9]><xml>
 <o:OfficeDocumentSettings>
  <o:RelyOnVML></o:RelyOnVML>
  <o:AllowPNG></o:AllowPNG>
 </o:OfficeDocumentSettings>
</xml><![endif]--><p>EMR Records the following order information and Alert. The coded values are not expected to be displayed to the user, but it is expected that the value selected has the identified meaning, and it is expected that the system will use the coded value when the attribute is conveyed in later transactions:</p><table border="1" cellpadding="0" cellspacing="0"><tbody><tr><td width="214">Entered BY<br></td><td width="230">Sandra Molina<br></td></tr><tr><td width="214">Ordering Provider<br></td><td width="230">Frank Smith<br></td></tr><tr><td width="214">Entering Organization<br></td><td width="230">Shoreline Pediatrics<br></td></tr><tr><td width="214">Vaccine Event information source<br></td><td width="230">New immunization record (NIP001 00)<br></td></tr><tr><td width="214">Date/Time of Start of Administration<br></td><td width="230">Current Date<br></td></tr><tr><td width="214">Vaccine Administered<br></td><td width="230">hepatitis B vaccine, pediatric or pediatric/adolescent dosage (CVX 08)<br>ENGERIX-B (NDC 58160-0820-43)<br></td></tr><tr><td width="214">Vaccine 2-D Data Matrix<br></td><td width="230"><img class="fr-dib fr-draggable" src="data:image/png;base64,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" style="width: 63px; height: 65.2009px;"><br></td></tr><tr><td width="214">Lot Number (Expired)<br></td><td width="230">6332FK18<br></td></tr><tr><td width="214">Substance Expiration Date (Expired)<br></td><td width="230">6/15/2019<br></td></tr><tr><td width="214">Substance Manufacturer Name<br></td><td width="230">GlaxoSmithKline Biologicals SA (MVX SKB)<br></td></tr><tr><td width="214">Alert<br></td><td width="230">Alerts user to expired lot<br></td></tr></tbody></table><p><br></p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Notes</th></tr><tr><td><p>No Note</p></td></tr></table></div><br/>
				</div>
			</tab>
			<tab heading="Description" vertical="false"><div class="panel-body"><table><tr><th>Description</th></tr><tr><td><p>The nurse documents administration lot number for the Hepatitis B vaccine:</p><p style="margin-left: 20px;">- Is prevented from ordering the Hepatitis B lot as it has expired.</p><p style="margin-left: 20px;">- Documents administration from a different lot that is not expired.</p></td></tr></table></div></tab><tab heading="Comments" vertical="false"><div class="panel-body"><table><tr><th>Comments</th></tr><tr><td><p>No Comments</p></td></tr></table></div></tab><tab heading="Pre-condition" vertical="false"><div class="panel-body"><table><tr><th>Pre-condition</th></tr><tr><td><p>Order is placed for Hepatitis B vaccine.</p></td></tr></table></div></tab><tab heading="Post-Condition" vertical="false"><div class="panel-body"><table><tr><th>Post-Condition</th></tr><tr><td><p>The provider has been notified of the expired Hepatitis B vaccination lot. Documentation of a lot to be administered that is not expired is recorded in the EMR.</p></td></tr></table></div></tab><tab heading="Test Objectives" vertical="false"><div class="panel-body"><table><tr><th>Test Objectives</th></tr><tr><td><p><strong>Notify of Vaccine Dose Expiration:&nbsp;</strong>The EHR or other clinical software system notifies the provider administering a vaccine if the dose chosen for administration is expired.</p></td></tr></table></div></tab><tab heading="Evaluation Criteria" vertical="false"><div class="panel-body"><table><tr><th>Evaluation Criteria</th></tr><tr><td><!--[if gte mso 9]><xml>
 <o:OfficeDocumentSettings>
  <o:RelyOnVML></o:RelyOnVML>
  <o:AllowPNG></o:AllowPNG>
 </o:OfficeDocumentSettings>
</xml><![endif]--><p>EMR Records the following order information and Alert. The coded values are not expected to be displayed to the user, but it is expected that the value selected has the identified meaning, and it is expected that the system will use the coded value when the attribute is conveyed in later transactions:</p><table border="1" cellpadding="0" cellspacing="0"><tbody><tr><td width="214">Entered BY<br></td><td width="230">Sandra Molina<br></td></tr><tr><td width="214">Ordering Provider<br></td><td width="230">Frank Smith<br></td></tr><tr><td width="214">Entering Organization<br></td><td width="230">Shoreline Pediatrics<br></td></tr><tr><td width="214">Vaccine Event information source<br></td><td width="230">New immunization record (NIP001 00)<br></td></tr><tr><td width="214">Date/Time of Start of Administration<br></td><td width="230">Current Date<br></td></tr><tr><td width="214">Vaccine Administered<br></td><td width="230">hepatitis B vaccine, pediatric or pediatric/adolescent dosage (CVX 08)<br>ENGERIX-B (NDC 58160-0820-43)<br></td></tr><tr><td width="214">Vaccine 2-D Data Matrix<br></td><td width="230"><img class="fr-dib fr-draggable" src="data:image/png;base64,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" style="width: 63px; height: 65.2009px;"><br></td></tr><tr><td width="214">Lot Number (Expired)<br></td><td width="230">6332FK18<br></td></tr><tr><td width="214">Substance Expiration Date (Expired)<br></td><td width="230">6/15/2019<br></td></tr><tr><td width="214">Substance Manufacturer Name<br></td><td width="230">GlaxoSmithKline Biologicals SA (MVX SKB)<br></td></tr><tr><td width="214">Alert<br></td><td width="230">Alerts user to expired lot<br></td></tr></tbody></table><p><br></p></td></tr></table></div></tab><tab heading="Notes" vertical="false"><div class="panel-body"><table><tr><th>Notes</th></tr><tr><td><p>No Note</p></td></tr></table></div></tab>
		</tabset>
	</div>
</fieldset>